In November of 2001, Dr. Marschall attended a conference on Chelation Therapy. Chelation Therapy is an alternative treatment for coronary artery bypass surgery or angioplasty. In Chelation Therapy, EDTA (ethylenediaminetetraacetic acid) is slowly infused into the blood stream over three hours. EDTA is an amino acid-like molecule that bonds with minerals such as calcium, iron, copper, and lead, and carries them to the kidneys where they are excreted. EDTA Chelation has commonly been used for lead poisoning, atherosclerosis and angina.
The history of EDTA Chelation begins with Alfred Werner, who received the Nobel Prize for his discovery of “complexion” chemistry in 1913, and has been researched consistently into the twenty-first century. In 1953 Dr. Norman Clarke and his associates at Providence Hospital in Detroit were the first to use EDTA Chelation Therapy in the treatment of coronary artery disease (CAD). In 1956 they reported on 20 patients that they had treated, and that 19 had a “remarkable” resolution of symptoms. Several studies continued to show vast improvements with evaluation with technetium 99m scans. These studies have shown marked improvement in their cerebral circulation and that the ejection fraction of the left ventricle had increased substantially. It was felt that the EDTA acted as a calcium channel blocker, thereby blocking the slow calcium currents in the arterial walls, permitting for increased arterial vasodilation and decreased back pressure in the arteries. One impressive study in 1989 by Drs, Casdorph and Farr reported on four patients who had exhausted all other medical treatments of their lower extremity arterial occlusive disease, and who had been affirmatively recommended for amputation. The disease was so advanced that pain was no longer a factor; the tissues were so dead that the nerves were no longer transmitting pain signals! Treatment was completely successful in 3 of the 4 cases, avoiding amputation completely.
There are numerous studies that have affirmatively demonstrated the benefits of Chelation Therapy. Why does mainstream medicine still remain skeptical? Detractors often site a study performed in 1991, by a group of Danish cardiovascular bypass surgeons. In this study they failed to include experts in Chelation Therapy as advisors and consultants. The doctors in this study violated their own double blind protocol. Not only did the doctors conducting the study know who was in which group, but 64% of the test patients also knew. At the conclusion of the study, the investigators concluded that both placebo and treatment groups showed improvement, but there was no significant difference between the two groups, and therefore the treatment with Chelation Therapy was a dud. They neglected to report that there was a 32% difference in improvement between each group, which showed that the EDTA group was considerably more diseased and therefore, the improvements enjoyed by the treatment group were harder earned and more significant. One must conclude that when one group improves more than twice what the other group achieved, there must have been some benefit from whatever the first group was receiving.
While this study is yet another demonstration of the effectiveness of Chelation Therapy, the researchers sought to discredit Chelation Therapy by virtue of their flawed study, and their biased interpretations and conclusions of the results. This frequently happens when mainstream medicine tries to “check out” natural non-invasive and cost-effective treatments for disease. Why is the allopathic medical community resistant to these new natural non-toxic advances in treatment? Medical colleges and research centers are funded by the drug companies and the old saying here may apply “Don’t bite the hand that feeds you.” It leaves us to question if the medical community is biased and at all concerned that Chelation Therapy may detract from their income.
After this research, the surgical treatments of CAD became the treatment of choice for CAD, and no further consideration was given Chelation Therapy by the allopathic medical community.
It is highly recommended that all people read the new edition of an already famous treatise on Chelation therapy authored by noted Chelation therapist, Elmer Cranton, M.D.. . His original book, Bypassing the Bypass, has already convinced many patients to seek Chelation therapy in lieu of the hazardous coronary artery bypass surgery. His new book, Bypassing Bypass Surgery should be in every doctor’s waiting room.
According to Dr. Cranton, “As for Chelation, its future is bright now, because its effectiveness is incontrovertible. Biased or uninformed physicians may call it untested, but no scientifically informed person can read the studies….without realizing that EDTA Chelation therapy is a formidable antagonist to cardiovascular disease.”
Now you might want to know who can benefit from chelation therapy? Chelation therapy as a component of a complete health plan can benefit the following challenges: cardiovascular disease (arteriosclerosis), toxic metal poisoning: lead, arsenic and cadmium, osteoporosis, diabetes, macular degeneration, high blood pressure, angina, intermittent claudication, environmental pollution due to petrochemical sensitivity, ulceration, gangrene.
Dr. Marschall screens for CAD with the CardioVision Device that measures arterial stiffness. If the disease is early onset, oral chelation is effective. Advanced conditions require EDTA chelation. Recent advances in EDTA administration have generated a suppository route of administration whereby 2 nightime suppositories are equivalent to one 3hour drip. This has made EDTA chelation more affordable and convenient. Patients can take treatment at home 3 times a week, usually for 8 weeks with a month off before restarting if required.
To make an appointment at the Natural Healing Clinic call (360) 457-1515.